Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,910.45
+10.20 (0.54%)
At close: Aug 21, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 484.88 billion as of August 21, 2026. Its market cap has increased by 39.46% in one year.
Market Cap
484.88B
Enterprise Value
495.61B
Revenue
101.26B
Ranking
n/a
PE Ratio
37.02
Stock Price
1,910.45
ChartMarket Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 484.88B, an increase of 14,964.22%. That is a compound annual growth rate of 23.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 484.88B | 34.70% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.02T |
| Dr. Reddy's Laboratories | 975.42B |
| Abbott India | 560.98B |
| GlaxoSmithKline Pharmaceuticals | 513.99B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |
| Caplin Point Laboratories | 195.43B |